FosunKairos Overview
- Status
-
Acquired/Merged
- Employees
-
148
- Latest Deal Type
-
Later Stage VC
- Investors
-
5
FosunKairos General Information
Description
Developer of tumour immunotherapy products designed to advance cell and gene therapy for cancer treatment. The company offers CAR-T and TCR-T pipelines, localised manufacturing capabilities, and integrated research and commercialisation expertise, enabling oncology care providers and biopharmaceutical sectors to improve access to advanced cell therapies and enhance treatment outcomes.
Contact Information
Website
www.fosunkairos.com(Operating Subsidiary)
Corporate Office
- Number 2277 Kangxin Road, Pudong New Area
- Shanghai, 201210
- China
Corporate Office
- Number 2277 Kangxin Road, Pudong New Area
- Shanghai, 201210
- China
FosunKairos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 26-May-2026 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 28-Apr-2026 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 05-Dec-2025 | Completed | Generating Revenue | |||
| 3. Merger/Acquisition | 13-Sep-2024 | Completed | Generating Revenue | |||
| 2. Secondary Transaction - Private | 27-Dec-2023 | Completed | Generating Revenue | |||
| 1. Joint Venture | 01-Apr-2017 | Completed | Generating Revenue |
FosunKairos Comparisons
Industry
Financing
Details
FosunKairos Competitors (48)
One of FosunKairos’s 48 competitors is Adaptimmune Therapeutics, a Formerly VC-backed company based in Abingdon, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Agenus | Formerly VC-backed | Lexington, MA | ||||
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Immunocore Holdings | Formerly VC-backed | Abingdon, United Kingdom |
FosunKairos Signals
FosunKairos Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jameho Investment | PE/Buyout | Minority | ||
| Kite Pharma | Corporation | Majority |
FosunKairos FAQs
-
Where is FosunKairos headquartered?
FosunKairos is headquartered in Shanghai, China.
-
What is the size of FosunKairos?
FosunKairos has 148 total employees.
-
What industry is FosunKairos in?
FosunKairos’s primary industry is Drug Discovery.
-
Is FosunKairos a private or public company?
FosunKairos is a Private company.
-
What is FosunKairos’s current revenue?
The current revenue for FosunKairos is .
-
How much funding has FosunKairos raised over time?
FosunKairos has raised $91.6M.
-
Who are FosunKairos’s investors?
Jameho Investment and Kite Pharma have invested in FosunKairos.
-
Who are FosunKairos’s competitors?
Adaptimmune Therapeutics, Agenus, Centrose, Sorrento Therapeutics, and Immunocore Holdings are some of the 48 competitors of FosunKairos.
-
When was FosunKairos acquired?
FosunKairos was acquired on 26-May-2026.
-
Who acquired FosunKairos?
FosunKairos was acquired by Fosun Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process